Literature DB >> 20700185

Automated estimation of implicit time and amplitude from the flicker electroretinogram.

M L Severns, M A Johnson, S A Merritt.   

Abstract

The electroretinogram (ERG) has been shown to yield sensitive and specific information about the development of neovascularization in ischemic disorders such as diabetic retinopathy and central retinal vein occlusion. However, even though the test is quick, easy to perform, and carries few risks, the ERG is poorly utilized in clinical situations because of the extended training period necessary for test interpretation. We have developed an algorithm that estimates the phase and amplitude of a 30-Hz flicker ERG and that is relatively insensitive to many forms of interference in ERG recordings. These estimates can be directly compared to established criteria for the risk of proliferative retinal disease.

Entities:  

Year:  1991        PMID: 20700185     DOI: 10.1364/AO.30.002106

Source DB:  PubMed          Journal:  Appl Opt        ISSN: 1559-128X            Impact factor:   1.980


  9 in total

1.  Evaluation of the LKC stimulator for focal ERG testing.

Authors:  J S Lyons; D J Sapper
Journal:  Doc Ophthalmol       Date:  2001-09       Impact factor: 2.379

2.  The flicker electroretinogram interocular amplitude ratio is a strong prognostic indicator of neovascularization in patients with central retinal vein occlusion.

Authors:  Hsi-Kung Kuo; Ming-Tse Kuo; Yung-Jen Chen; Pei-Chang Wu; Chih-Hsin Chen; Yi-Hao Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-08       Impact factor: 3.117

3.  Flicker electroretinogram recorded with portable ERG device in prematurely born schoolchildren with and without ROP.

Authors:  Manca Tekavčič Pompe; Maja Šuštar
Journal:  Doc Ophthalmol       Date:  2019-04-11       Impact factor: 2.379

4.  The effects of physostigmine on the electroretinogram in the beagle dog.

Authors:  R D Jones; B F Hamilton; P D Dass
Journal:  Vet Res Commun       Date:  1995       Impact factor: 2.459

5.  A novel device for accurate and efficient testing for vision-threatening diabetic retinopathy.

Authors:  April Y Maa; William J Feuer; C Quentin Davis; Ensa K Pillow; Tara D Brown; Rachel M Caywood; Joel E Chasan; Stephen R Fransen
Journal:  J Diabetes Complications       Date:  2015-12-09       Impact factor: 2.852

6.  Constant luminance (cd·s/m2) versus constant retinal illuminance (Td·s) stimulation in flicker ERGs.

Authors:  C Quentin Davis; Olga Kraszewska; Colette Manning
Journal:  Doc Ophthalmol       Date:  2017-02-03       Impact factor: 2.379

7.  Mydriasis-Free Flicker Electroretinograms in 204 Healthy Children Aged 0-18 Years: Reference Data From Two Cohorts.

Authors:  Ting Zhang; Jinglin Lu; Limei Sun; Songshan Li; Li Huang; You Wang; Zeyu Li; Liming Cao; Xiaoyan Ding
Journal:  Transl Vis Sci Technol       Date:  2021-11-01       Impact factor: 3.283

8.  Evaluation of cone function by a handheld non-mydriatic flicker electroretinogram device.

Authors:  Natsuko Nakamura; Kaoru Fujinami; Yoshinobu Mizuno; Toru Noda; Kazushige Tsunoda
Journal:  Clin Ophthalmol       Date:  2016-06-30

9.  Screening for diabetic retinopathy using new mydriasis-free, full-field flicker ERG recording device.

Authors:  Motonobu Fukuo; Mineo Kondo; Akira Hirose; Harumi Fukushima; Kengo Ikesugi; Masahiko Sugimoto; Kumiko Kato; Yasuko Uchigata; Shigehiko Kitano
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.